Therefore, we suggest that the -609 C/C genotype promotes FNTB transcriptional activity, RAS farnesylation and RAS signalling, which, in turn, may contribute to a more aggressive breast cancer phenotype with a high risk of relapse and poor prognosis. Here, FNTB is linked to breast carcinoma.